CALC CalciMedica, Inc.
Company Analysis
Latest News
🟢 CalciMedica is trading 6.65% up in after-hours trading after Guggenheim's Buy initiation
CalciMedica is trading 6.65% up at $0.62 after Guggenheim initiated coverage on August 20, 2026, with a Buy rating and a $9.00 price target. - The positive...
🔴 CalciMedica is trading 5.6% down today after reverse split approval
CalciMedica is trading 5.6% down at $0.58 after shareholders approved a reverse stock split ranging from 1-for-2 to 1-for-10 and expanded the company’s equity...
CalciMedica Stockholders Approve Reverse Stock Split and Incentive Plan Expansion
CalciMedica, Inc. announced that stockholders approved several key proposals at its 2026 Annual Meeting of Stockholders held on August 19, 2026. The approved...
🟢 CalciMedica is trading 11.17% up in pre-market as XBI rises 2.27%
CalciMedica is trading at $0.68, up 11.17% in pre-market, primarily on biotech-sector strength. - No new CalciMedica company-specific announcement was...
🟢 CalciMedica is trading 6% up in pre-market as biotech ETF XBI gains 2.27%
CalciMedica is trading at $0.65, up +6.02%, as a 2.27% pre-market gain in biotech ETF XBI points to sector-wide risk appetite. - No new company-specific...
🔴 CalciMedica is trading 5.58% down today
CalciMedica is trading 5.58% down at $0.61, with no clearly reported company-specific announcement explaining the August 19, 2026 move. - The company’s annual...
🟢 CalciMedica is trading 5% up in after-hours trading; no new company-specific announcement directly explaining the move
CalciMedica is trading 5.17% up now at $0.71 after closing at $0.68 on August 14, 2026; no new company-specific announcement directly explaining the...
CalciMedica Rallies 11% on FDA Nod and Cash Lifeline, but Can a Sub-Dollar Stock Deliver on Its Pancreatitis Bet?
Shares of CalciMedica surged to $0.69, up 11% from the prior close, as investors digested a pair of catalysts: the FDA's agreement on a clearer path for the...
🟢 CalciMedica is trading 11% up today as FDA aligns on Auxora trial endpoint
CalciMedica is trading 11% up at $0.69 as investors focus on FDA alignment for Auxora’s Phase 2b acute-pancreatitis trial despite a wider-than-expected...
🟢 CalciMedica is trading 8.08% up today after July PPI showed no monthly growth
CalciMedica is trading at $0.67, up +8.08%, as U.S. markets rally after July PPI showed no monthly growth, below the expected 0.2% increase. - The S&P 500,...
CalciMedica misses second quarter 2026 EPS estimates as FDA aligns on pancreatitis trial design
CalciMedica reported a second quarter 2026 net loss of $0.45 per share, missing consensus estimates by $0.12. Despite the wider loss, the company achieved a...
🟢 CalciMedica is trading 5% up in pre-market
CalciMedica is trading 5.16% up at $0.69 after closing at $0.66 on August 10, 2026, with no new company-specific announcement or clear overnight catalyst...
🟢 CalciMedica is trading 5% up in after-hours trading, with no clear company-specific catalyst identified
CalciMedica is trading 5% up at $0.69 after closing at $0.66 on August 10, 2026, with no clear company-specific catalyst identified for the after-hours...
🔴 CalciMedica is trading 5.45% down today; no clear catalyst identified
CalciMedica is trading at $0.65, reflecting a -5.45% change, with no clear catalyst identified. - No new August 10, 2026 company announcement surfaced in...
CalciMedica, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Consensus estimates for CalciMedica’s Q2 2026 report reflect zero revenue and a projected EPS loss of -$0.33, while the current share price of $0.75 remains...
🟢 CalciMedica is trading 8.4% up in pre-market with no clear catalyst identified
CalciMedica is trading 8.4% up in pre-market at $0.77, after rising from the August 6 close of $0.71; no new company-specific announcement or reliable report...
🔴 CalciMedica is trading 5.22% down today on a sharp pullback following recent volatility
CalciMedica is trading at $0.75 (-5.22%), pulling back from its August 4 close of $0.80 in a move consistent with recent short-term volatility and price...
🟢 CalciMedica is trading 15.7% up today despite no fresh company-specific catalyst
CalciMedica is trading at $0.92 (+15.72%) in pre-market despite no fresh company-specific catalyst, earnings release, or FDA update being identified. • The...
🟢 CalciMedica is trading 10.4% up today as stock stabilizes after FDA-related swings
CalciMedica is trading 10.4% up at $0.82 as the stock continues to stabilize following sharp FDA-related volatility over the past several sessions. • The...
🟢 CalciMedica is trading 5.6% up today as it stabilizes after FDA-driven volatility
CalciMedica is trading 5.6% up today at $0.78 as the stock stabilizes following sharp swings tied to its recent FDA-related rally and subsequent sell-off. •...